FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082116 [Registered on: 11/03/2025] Trial Registered Prospectively
Last Modified On: 10/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   A clinical study to reduce the symptoms of Kasa Roga in children with Balachaturbhadra churna.  
Scientific Title of Study   A clinical study on Kasa roga in children with Balachaturbhadra churna 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Urmila Bariha 
Designation  2nd year PG Scholar 
Affiliation  Gopabandhu Ayurveda Mahavidyalaya and hospital 
Address  Post graduate Department of Kaumarbhritya Gopabandhu Ayurveda Mahavidyalaya VIP road Puri

Puri
ORISSA
752002
India 
Phone  7077185584  
Fax    
Email  urmilabariha1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sangita Prusty 
Designation  Reader and H.O.D, Department of Kaumarbhritya 
Affiliation  Gopabandhu Ayurveda Mahavidyalaya and Hospital 
Address  Post graduate Department of OPD and IPD of Kaumarbhritya Gopabandhu Ayurveda Mahavidyalaya VIP road Puri

Puri
ORISSA
752002
India 
Phone  7008329522  
Fax    
Email  prustydrsangita@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sangita Prusty 
Designation  Reader & H. O. D, Department of Kaumarbhritya 
Affiliation  Gopabandhu Ayurveda Mahavidyalaya And Hospital 
Address  Post graduate Department of OPD and IPD of Kaumarbhritya Gopabandhu Ayurveda Mahavidyalaya VIP road Puri

Puri
ORISSA
752002
India 
Phone  7008329522  
Fax    
Email  prustydrsangita@gmail.com  
 
Source of Monetary or Material Support  
Gopabandhu Ayurveda Mahavidyalaya and Hospital, Puri VIP Road, Odisha Pin-752002 
 
Primary Sponsor  
Name  Dr Urmila Bariha 
Address  Post Graduate department of Kaumarbhritya Gopabandhu Ayurveda Mahavidyalaya and Hospital, Puri ODISHA Pin 752002 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Urmila Bariha  Gopabandhu Ayurveda Mahavidyalaya and Hospital, puri  PG department of Kaumarbhritya Gopabandhu Ayurveda Mahavidyalaya and Hospital, puri VIP road, ODISHA Pin-752002
Puri
ORISSA 
07077185584

urmilabariha1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Gopabandhu Ayurveda Mahavidyalaya and Hospital VIP Road PURI 752002   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J00-J06||Acute upper respiratory infections. Ayurveda Condition: KASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  4.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Patients presenting with signs and symptoms of vataja, pittaj and kaphaja kasa roga.
Those who have not received any medication for cough and cold in last 24 hours.  
 
ExclusionCriteria 
Details  1-patient less than 4 year of age & above 12 year.
2-khsyataja and khsyaja kasa
3- kasa associated with fever, bronchial asthma, TB, severe lower RTI.
4- History of malignancy or any other congenital, anatomical abnormalities of chest & respiratory system.
5-kasa associated with severe malnutrition
6- kasa associated with neurological disorder.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To reduce the classical symptoms of Kasa and study the efficacy of drug Balachaturbhadra churna.   14 days 
 
Secondary Outcome  
Outcome  TimePoints 
To reduce the classical symptoms of Kasa roga.   14 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="14" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Respiratory complaints are well defined condition in medical science and cough is the most common complain among them.Kasa roga seems to be very simple disease but if it is neglected or mismanaged it may result in disease with poor prognostic condition. The drug Balachaturbhadra churna has maximum ingredients having  kapha-pitta samaka  properties and also tetracyclic triterpenes,Tannic acid of karkatashringi & ativisa has antioxidant properties, rotundone of Musta have anti-inflammatory, hepatoprotective, anti-pyretic properties, Pippali has many properties, including being acrid, stimulant, appetizer,anti-oxidant, and anti-tussive,that helps in easy expectoration. Thus, I expect Balachaturbhadra churna may be helpful in curing the disease and will be beneficial to society. 
Close